Dynavax Technologies Corporatio - stock earnings
DVAX Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | 219000 USD | 55.6 million USD |
2023Q3 | 14.3 million USD | 69.5 million USD |
2023Q2 | 3.4 million USD | 60.2 million USD |
2023Q1 | -24.3 million USD | 46.9 million USD |
2022Q4 | 67.7 million USD | 184.5 million USD |
2022Q3 | 63.8 million USD | 167.7 million USD |
2022Q2 | 128.8 million USD | 256.5 million USD |
2022Q1 | 32.7 million USD | 114.0 million USD |
2021Q4 | 99.8 million USD | 195.1 million USD |
2021Q3 | -28.4 million USD | 108.3 million USD |
2021Q2 | 4.5 million USD | 52.8 million USD |
2021Q1 | 891000 USD | 83.3 million USD |
2020Q4 | -15.5 million USD | 19.6 million USD |
2020Q3 | 4.4 million USD | 13.4 million USD |
2020Q2 | -51.6 million USD | 2.7 million USD |
2020Q1 | -12.6 million USD | 10.9 million USD |
2019Q4 | -36.8 million USD | 10.6 million USD |
2019Q3 | -33.5 million USD | 10.6 million USD |
2019Q2 | -42.7 million USD | 8.3 million USD |
2019Q1 | -39.7 million USD | 5.8 million USD |
2018Q4 | -40.0 million USD | 5.3 million USD |
2018Q3 | -40.5 million USD | 1.5 million USD |
2018Q2 | -39.4 million USD | 1.3 million USD |
2018Q1 | -39.0 million USD | 165000 USD |
2017Q4 | -27.4 million USD | 21000 USD |
2017Q3 | -22.1 million USD | 53000 USD |
2017Q2 | -20.3 million USD | 105000 USD |
2017Q1 | -25.3 million USD | 148000 USD |
2016Q4 | -21.7 million USD | 7.3 million USD |
2016Q3 | -34.7 million USD | 162000 USD |
2016Q2 | -29.0 million USD | 2.6 million USD |
2016Q1 | -27.0 million USD | 942000 USD |
2015Q4 | -26.9 million USD | 685000 USD |
2015Q3 | -30.1 million USD | 1.2 million USD |
2015Q2 | -23.6 million USD | 1.6 million USD |
2015Q1 | -26.2 million USD | 627000 USD |
2014Q4 | -22.3 million USD | 2.3 million USD |
2014Q3 | -29.8 million USD | 2.2 million USD |
2014Q2 | -24.8 million USD | 3.0 million USD |
2014Q1 | -13.8 million USD | 3.5 million USD |
2013Q4 | -13.1 million USD | 2.8 million USD |
2013Q3 | -15.7 million USD | 2.9 million USD |
2013Q2 | -17.2 million USD | 3.4 million USD |
2013Q1 | -20.8 million USD | 2.1 million USD |
2012Q4 | -20.5 million USD | 1.8 million USD |
2012Q3 | -17.8 million USD | 2.9 million USD |
2012Q2 | -15.1 million USD | 2.7 million USD |
2012Q1 | -16.5 million USD | 2.4 million USD |
2011Q4 | -4.3 million USD | 11.4 million USD |
2011Q3 | -15.2 million USD | 1.2 million USD |
2011Q2 | -10.6 million USD | 7.3 million USD |
2011Q1 | -18.5 million USD | 1.7 million USD |
2010Q4 | -15.1 million USD | 1.8 million USD |
2010Q3 | -5.0 million USD | 11.6 million USD |
2010Q2 | -28.0 million USD | 2.2 million USD |
2010Q1 | -9.2 million USD | 8.3 million USD |
2009Q4 | -30.3 million USD | 2.2 million USD |
2009Q3 | -9.5 million USD | 2.9 million USD |
2009Q2 | 4.1 million USD | 15.9 million USD |
2009Q1 | 5.1 million USD | 19.3 million USD |
2008Q4 | 3.1 million USD | 11.9 million USD |
2008Q3 | -5.4 million USD | 8.9 million USD |
2008Q2 | -6.1 million USD | 10.0 million USD |
2008Q1 | -12.4 million USD | 6.3 million USD |
2007Q4 | -12.1 million USD | 9.3 million USD |
2007Q3 | -17.1 million USD | 1.0 million USD |
2007Q2 | -17.7 million USD | 1.8 million USD |
2007Q1 | -13.1 million USD | 2.0 million USD |
2006Q4 | -16.5 million USD | 2.4 million USD |
2006Q3 | -12.2 million USD | 1.6 million USD |
2006Q2 | -15.3 million USD | 529000 USD |
2006Q1 | -8.2 million USD | 288000 USD |
2005Q4 | -8.8 million USD | 600000 USD |
2005Q3 | -8.3 million USD | 404000 USD |
2005Q2 | -8.6 million USD | 953000 USD |
2005Q1 | 5.1 million USD | 12.7 million USD |
2004Q4 | -5.2 million USD | 2.5 million USD |
2004Q3 | -4.0 million USD | 3.7 million USD |
2004Q2 | -2.9 million USD | 5.5 million USD |
2004Q1 | -3.9 million USD | 3.2 million USD |
2003Q4 | -4.5 million USD | 707000 USD |
2003Q3 | -4.1 million USD | 23000 USD |
2003Q2 | -4.0 million USD | 96000 USD |
2003Q1 | -4.7 million USD | ? USD |
2002Q4 | ? USD | 1.4 million USD |
2001Q4 | ? USD | 2.4 million USD |
DVAX Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -6.4 million USD | 232.3 million USD |
2022 | 293.2 million USD | 722.7 million USD |
2021 | 76.7 million USD | 439.4 million USD |
2020 | -91.8 million USD | 46.6 million USD |
2019 | -151.4 million USD | 35.2 million USD |
2018 | -158.9 million USD | 8.2 million USD |
2017 | -95.2 million USD | 327000 USD |
2016 | -112.4 million USD | 11.0 million USD |
2015 | -106.8 million USD | 4.1 million USD |
2014 | -90.7 million USD | 11.0 million USD |
2013 | -66.7 million USD | 11.3 million USD |
2012 | -69.9 million USD | 9.7 million USD |
2011 | -48.6 million USD | 21.6 million USD |
2010 | -57.3 million USD | 24.0 million USD |
2009 | -30.6 million USD | 40.3 million USD |
2008 | -20.8 million USD | 37.1 million USD |
2007 | -60.0 million USD | 14.1 million USD |
2006 | -52.1 million USD | 4.8 million USD |
2005 | -20.6 million USD | 14.7 million USD |
2004 | -16.0 million USD | 14.8 million USD |
2003 | -17.4 million USD | 826000 USD |
2002 | -18.0 million USD | 1.4 million USD |
2001 | -18.4 million USD | 2.4 million USD |
2000 | -26.7 million USD | ? USD |
DVAX
Price: $11.72
52 week price:
Earnings Per Share: -0.05 USD
P/E Ratio: 30.44
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 1.5 million
Ebitda: -21.6 millionMarket Capitalization: 1.5 billion